107 related articles for article (PubMed ID: 17556016)
1. Hyperglycemia down-regulates apolipoprotein M expression in vivo and in vitro.
Zhang X; Jiang B; Luo G; Nilsson-Ehle P; Xu N
Biochim Biophys Acta; 2007 Jul; 1771(7):879-82. PubMed ID: 17556016
[TBL] [Abstract][Full Text] [Related]
2. Hyperglycemia-induced downregulation of apolipoprotein M expression is not via the hexosamine pathway.
Jiang B; Zhang X; Di D; Luo G; Shi Y; Zhang J; Berggren-Söderlund M; Nilsson-Ehle P; Xu N
Lipids Health Dis; 2015 Sep; 14():110. PubMed ID: 26377577
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of apolipoprotein M expression is mediated by phosphatidylinositol 3-kinase in HepG2 cells.
Xu N; Ahrén B; Jiang J; Nilsson-Ehle P
Biochim Biophys Acta; 2006 Feb; 1761(2):256-60. PubMed ID: 16542871
[TBL] [Abstract][Full Text] [Related]
4. Suppression of apolipoprotein M expression and secretion in alloxan-diabetic mouse: Partial reversal by insulin.
Xu N; Nilsson-Ehle P; Ahrén B
Biochem Biophys Res Commun; 2006 Apr; 342(4):1174-7. PubMed ID: 16516154
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta down-regulates apolipoprotein M in HepG2 cells.
Xu N; Hurtig M; Zhang XY; Ye Q; Nilsson-Ehle P
Biochim Biophys Acta; 2004 Jul; 1683(1-3):33-7. PubMed ID: 15238217
[TBL] [Abstract][Full Text] [Related]
6. Intralipid decreases apolipoprotein M levels and insulin sensitivity in rats.
Zheng L; Feng Y; Shi Y; Zhang J; Mu Q; Qin L; Berggren-Söderlund M; Nilsson-Ehle P; Zhang X; Luo G; Xu N
PLoS One; 2014; 9(8):e105681. PubMed ID: 25144649
[TBL] [Abstract][Full Text] [Related]
7. [Reduced expression and secretion of apolipoprotein M in fat-fed, streptozotocin-diabetic rats is partially reversed by an artificial ligand of PPARγ].
Qu X; Zhao S; Gao J; Hu M; Dong L; Zhang X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Aug; 37(8):796-801. PubMed ID: 22954914
[TBL] [Abstract][Full Text] [Related]
8. Leptin inhibits apolipoprotein M transcription and secretion in human hepatoma cell line, HepG2 cells.
Luo G; Hurtig M; Zhang X; Nilsson-Ehle P; Xu N
Biochim Biophys Acta; 2005 May; 1734(2):198-202. PubMed ID: 15904876
[TBL] [Abstract][Full Text] [Related]
9. Estrogen upregulates hepatic apolipoprotein M expression via the estrogen receptor.
Wei J; Shi Y; Zhang X; Feng Y; Luo G; Zhang J; Mu Q; Tang Y; Yu Y; Pan L; Nilsson-Ehle P; Xu N
Biochim Biophys Acta; 2011 Dec; 1811(12):1146-51. PubMed ID: 21816233
[TBL] [Abstract][Full Text] [Related]
10. Rosiglitazone enhances apolipoprotein M (Apom) expression in rat's liver.
Luo G; Feng Y; Zhang J; Mu Q; Shi Y; Qin L; Zheng L; Berggren-Söderlund M; Nilsson-Ehle P; Zhang X; Xu N
Int J Med Sci; 2014; 11(10):1015-21. PubMed ID: 25136257
[TBL] [Abstract][Full Text] [Related]
11. Both leptin and leptin-receptor are essential for apolipoprotein M expression in vivo.
Xu N; Nilsson-Ehle P; Hurtig M; Ahrén B
Biochem Biophys Res Commun; 2004 Sep; 321(4):916-21. PubMed ID: 15358114
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor downregulates apolipoprotein M expression by inhibiting Foxa2 in a Nur77-dependent manner.
Hu YW; Zheng L; Wang Q; Zhong TY; Yu X; Bao J; Cao NN; Li B; Si-Tu B
Rejuvenation Res; 2012 Aug; 15(4):423-34. PubMed ID: 22877565
[TBL] [Abstract][Full Text] [Related]
13. Palmitic acid suppresses apolipoprotein M gene expression via the pathway of PPARβ/δ in HepG2 cells.
Luo G; Shi Y; Zhang J; Mu Q; Qin L; Zheng L; Feng Y; Berggren-Söderlund M; Nilsson-Ehle P; Zhang X; Xu N
Biochem Biophys Res Commun; 2014 Feb; 445(1):203-7. PubMed ID: 24508264
[TBL] [Abstract][Full Text] [Related]
14. Effects of platelet-activating factor, tumor necrosis factor, and interleukin-1alpha on the expression of apolipoprotein M in HepG2 cells.
Xu N; Zhang XY; Dong X; Ekström U; Ye Q; Nilsson-Ehle P
Biochem Biophys Res Commun; 2002 Apr; 292(4):944-50. PubMed ID: 11944906
[TBL] [Abstract][Full Text] [Related]
15. Dihydrotestosterone regulating apolipoprotein M expression mediates via protein kinase C in HepG2 cells.
Yi-zhou Y; Bing C; Ming-qiu L; Wei W; Ru-xing W; Jun R; Liu-yan W; Zhao-hui J; Yong J; Guo qing J; Jian Z
Lipids Health Dis; 2012 Dec; 11():168. PubMed ID: 23216709
[TBL] [Abstract][Full Text] [Related]
16. Effect of simvastatin on the expression and regulation mechanism of apolipoprotein M.
Yang L; Zhao S
Int J Mol Med; 2012 Mar; 29(3):510-4. PubMed ID: 22160096
[TBL] [Abstract][Full Text] [Related]
17. The association between apolipoprotein M and insulin resistance varies with country of birth.
Memon AA; Bennet L; Zöller B; Wang X; Palmér K; Dahlbäck B; Sundquist J; Sundquist K
Nutr Metab Cardiovasc Dis; 2014 Nov; 24(11):1174-80. PubMed ID: 24984825
[TBL] [Abstract][Full Text] [Related]
18. Urinary apolipoprotein M could be used as a biomarker of acute renal injury: an ischemia-reperfusion injury model of kidney in rat.
Xu XL; Mao QY; Luo GH; Nilsson-Ehle P; He XZ; Xu N
Transplant Proc; 2013; 45(6):2476-9. PubMed ID: 23953565
[TBL] [Abstract][Full Text] [Related]
19. Berberine reduces gut-vascular barrier permeability via modulation of ApoM/S1P pathway in a model of polymicrobial sepsis.
Li Y; Zhou J; Qiu J; Huang Z; Wang W; Wu P; Feng A
Life Sci; 2020 Nov; 261():118460. PubMed ID: 32961234
[TBL] [Abstract][Full Text] [Related]
20. Effects of simvastatin on apolipoprotein M in vivo and in vitro.
Zhang X; Mao S; Luo G; Wei J; Berggren-Söderlund M; Nilsson-Ehle P; Xu N
Lipids Health Dis; 2011 Jul; 10():112. PubMed ID: 21729290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]